gategroup Successfully Upsizes and Reprices Term Loan B, Strengthening Financial Flexibility and Reducing Funding Costs
Globenewswire· 2025-11-21 17:29
Core Insights - gategroup Holding AG successfully upsized and repriced its Term Loan B facilities, increasing its euro-denominated facility by EUR 215 million and its U.S. dollar-denominated facility by USD 75 million, enhancing liquidity and financial flexibility for long-term growth [1][2] Group 1: Financial Performance - The transaction experienced strong investor demand, leading to a margin reduction of 75 basis points to 350 basis points, which was better than initially expected [2] - gategroup maintains a well-balanced capital structure and strong liquidity position, allowing the company to execute its growth strategy and address upcoming debt maturities efficiently [3] Group 2: Company Overview - gategroup is a global leader in airline catering, retail-on-board, and hospitality products and services, operating over 200 units in more than 60 countries [4]
Onfolio Holdings Receives $4.75M in Investment Proceeds
Globenewswire· 2025-11-21 17:20
WILMINGTON, Del., Nov. 21, 2025 (GLOBE NEWSWIRE) -- Onfolio Holdings Inc. (Nasdaq: ONFO, ONFOW) (OTC: ONFOP) (the "Company" or "Onfolio"), a company that combines digital assets, DeFi yield, and cash-flowing online businesses, today announced that it has received $4.75 million in investment proceeds under its previously announced financing agreement. The Company has allocated approximately $2.35 million toward business growth initiatives, repayment of debt and working capital, and approximately $2.4 million ...
Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study
Globenewswire· 2025-11-21 17:07
Core Insights - Revive Therapeutics Ltd. is conducting a research study on Bucillamine as a potential treatment for nerve agent exposure in collaboration with Defence R&D Canada [1][2] - The study is ongoing, and final findings will be released with DRDC's authorization [2] - Revive is focused on developing therapeutics for infectious diseases and medical countermeasures, leveraging various FDA regulatory incentives [3] Company Overview - Revive Therapeutics specializes in the research and development of therapeutics for infectious diseases and medical countermeasures [3] - The company is exploring Bucillamine for nerve agent exposure and long COVID, alongside developing Psilocybin and molecular hydrogen therapeutics [3] Collaboration Details - The collaboration with DRDC provides expertise and infrastructure to support the development of medical countermeasures against nerve agent-induced brain injury [1]
Vranken-Pommery Monopole : Licensing of the Pompadour Brand to Vranken-Pommery Monopole
Globenewswire· 2025-11-21 17:00
Reims, November 21, 2025 On October 1, Vranken-Pommery Monopole decided to accept the offer from the Lanson-BCC Group, which was more attractive than that of the Vranken Company, for the sale of the Heidsieck & Co Monopole brand. In order to provide Vranken-Pommery Monopole with additional resources, strengthen its commercial development in the premium segment, and provide it with a cost-sharing arrangement, Compagnie Vranken has decided to license the Pompadour brand to it, with marketing set to begin in l ...
Plug Power Nets $399 Million in Cash Following Successful Financing; Eliminates First Lien and Fully Funds Current Business Plan
Globenewswire· 2025-11-21 16:51
Core Viewpoint - Plug Power Inc. successfully closed a $375 million offering of 6.75% convertible notes, raising a total of $431.25 million, which will significantly enhance its financial position and flexibility [1][2][4] Financial Impact - The proceeds from the offering will be used to retire high-cost 15% debt, refinance 2026 convertible notes, and eliminate a first lien, leading to reduced interest expenses and a simplified capital structure [2][4] - The refinancing extends Plug's lower cost of capital through an eight-year balloon note, preserving liquidity and eliminating near-term principal repayment pressure [3][4] Business Strategy - The financing allows Plug to support sales growth in material handling and electrolyzers as customer demand accelerates, with a strengthened balance sheet providing stability for commercial momentum [4] - Plug has the manufacturing capacity to meet its growth trajectory, with a fully funded business plan based on current operating expectations [3][4] Industry Position - Plug Power is a leader in the hydrogen economy, providing a comprehensive ecosystem that includes electrolyzers, fuel cell systems, and fueling infrastructure, contributing to energy independence and decarbonization [5][6] - The company has deployed over 72,000 fuel cell systems and 275 fueling stations, and operates hydrogen plants capable of producing 40 tons per day [6]
HII Delivers Virginia-Class Submarine Massachusetts (SSN 798) to U.S. Navy
Globenewswire· 2025-11-21 16:45
Core Points - HII's Newport News Shipbuilding division has delivered the Virginia-class fast-attack submarine Massachusetts (SSN 798) to the U.S. Navy, marking the 12th Virginia-class submarine delivered by NNS and the 25th built under the teaming agreement with General Dynamics Electric Boat [1][2] - The delivery of Massachusetts is seen as a significant milestone in increasing the pace of submarine construction, with over 10,000 shipbuilders and numerous suppliers involved in its construction [2] - The submarine was christened in May 2023 by Sheryl Sandberg, highlighting the involvement of notable figures in the project [3] Company Overview - HII is recognized as the largest military shipbuilder in the U.S., with a history of over 135 years in advancing national security [7] - The company employs a workforce of 44,000 and focuses on delivering a wide range of defense capabilities, including ships, unmanned systems, cyber solutions, and artificial intelligence [6][7] - HII's mission is to provide powerful ships and all-domain solutions to protect peace and freedom globally [6]
UBISOFT ANNOUNCES THE COMPLETION OF TENCENT’S STRATEGIC INVESTMENT IN VANTAGE STUDIOS
Globenewswire· 2025-11-21 16:45
Core Insights - Ubisoft has completed Tencent's strategic investment in Vantage Studios, securing a €1.16 billion cash investment, which values Vantage Studios at a pre-money enterprise value of €3.8 billion, marking a significant milestone in Ubisoft's transformation [1][5][4] Group 1: Investment Details - The investment from Tencent will help deleverage Ubisoft's balance sheet and support selected investments across the Group, providing enhanced financial flexibility for strategic transformation [3][5] - Tencent now holds a 26.32% economic interest in Vantage Studios, which remains under Ubisoft's exclusive control [4][5] Group 2: Vantage Studios Operations - Vantage Studios became fully operational on October 1, 2025, focusing on accelerating the growth of Ubisoft's three largest franchises: Assassin's Creed, Far Cry, and Tom Clancy's Rainbow Six [2][5] - The studio operates under principles of autonomy, focus, and player centricity, with a dedicated leadership team [2][5] Group 3: Shareholders' Agreement - The Shareholders' Agreement includes minority protection rights for Tencent, a five-year lock-up on Vantage Studios' securities held by Tencent, and stipulations ensuring Ubisoft maintains majority control for at least two years [6][7] - In the event of a change of control of Ubisoft, there are call and put options related to Tencent's interest in Vantage Studios, with specific pricing mechanisms based on fair market value [7]
Aspo Plc: Share repurchase 21.11.2025
Globenewswire· 2025-11-21 16:30
Core Viewpoint - Aspo Plc has conducted a share repurchase, acquiring 2,000 shares at an average price of €6.6286 per share, totaling €13,257.20, which increases its total holdings to 38,555 shares [1]. Group 1: Share Repurchase Details - The share repurchase occurred on November 21, 2025, on the Helsinki Stock Exchange [1]. - The average price per share for the repurchase was €6.6286 [1]. - The total cost of the repurchase was €13,257.20 [1]. Group 2: Compliance and Regulations - The share buybacks are executed in compliance with Regulation No. 596/2014 of the European Parliament and Council (MAR) Article 5 [1]. - The buybacks also adhere to the Commission Delegated Regulation (EU) 2016/1052 [1].
International Land Alliance Secures up to $50 Million in Institutional Financing and Enters Agreement to Provide Expert Real Estate Services
Globenewswire· 2025-11-21 16:15
Advances Rancho Costa Verde Expansion and Acquisitions, Accelerates Strategic Growth and Creates a Long-Term Revenue Stream for Operations San Diego, CA, Nov. 21, 2025 (GLOBE NEWSWIRE) -- International Land Alliance, Inc. (OTCQB: ILAL) (“ILAL” or the “Company”), a global real estate investment and development firm, announced today that it has secured an up to $50 million financing facility from an institutional investor. This financing marks one of the most significant capital commitments in ILAL’s history ...
Interim consolidated financial statement of Grigeo Group AB covering 9 months of 2025
Globenewswire· 2025-11-21 16:00
Group Performance Summary - The Grigeo Group AB achieved a consolidated sales turnover of EUR 173.0 million over the first nine months of 2025, an increase of EUR 14.9 million compared to the same period in 2024 [1] - The Group reported a profit before taxes of EUR 15.4 million, which is EUR 1.2 million less than in the same period in 2024 [2] - EBITDA for the Group increased by EUR 1.0 million to reach EUR 24.7 million compared to the first nine months of 2024 [2] Financial Performance Indicators - Revenue for the first nine months of 2025 was EUR 173.0 million, reflecting a 9% increase from EUR 158.2 million in 2024 [2] - EBITDA rose to EUR 24.7 million, marking a 4% increase from EUR 23.7 million in the previous year [2] - Profit before tax (EBT) decreased by 7% from EUR 16.7 million in 2024 to EUR 15.4 million in 2025 [2]